APOA5 antibody (truncated)
Quick Overview for APOA5 antibody (truncated) (ABIN2464012)
Target
See all APOA5 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- truncated
-
Immunogen
- Ni-NTA purified truncated recombinant human APOA5 expressed in E. Coli strain BL21 (DE3).
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
Western Blot, ELISA.
Dilution:
Western Blot:1:500 - 1,000
ELISA:Determining optimal working dilutions by titration test.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Ascitic fluid containing 0.03 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
Storage
- -20 °C
-
Storage Comment
- Apoa5(bd) monoclonal antibody can be stored at -20 °C, stable for one year.
-
-
- APOA5 (Apolipoprotein A-V (APOA5))
-
Alternative Name
- Apoa5
-
Background
- Apolipoprotein A5 (ApoA5) is fast gaining attention as a key regulator of serum triglyceride concentrations. An ApoA5 mouse knock-out model produced an approximately four fold increase in serum triglyc erides, whereas a knock-in model with human ApoA5 produced 50 70 % lower concentrations of mouse serum triglycerides. In addition, peroxisome proliferator-activated receptor-_ agonists, which are used clinically to lower serum triglyceride concentrations, cause increased ApoA5 mRNA expression. Recently, it was demonstrated that ApoA5 is present in human serum detected by polyclonal antibodies against both the NH2 and COOH termini, although at much lower concentration than other apolipoproteins.
-
Gene ID
- 116519
-
UniProt
- Q6Q788
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
Target
-